Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization.

about

Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization.

Item

http://www.wikidata.org/entity/Q48206047

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Application of EGFR inhibitor ...... atheter arterial embolization.

@en

Application of EGFR inhibitor ...... atheter arterial embolization.

@nl

type

Item

label

Application of EGFR inhibitor ...... atheter arterial embolization.

@en

Application of EGFR inhibitor ...... atheter arterial embolization.

@nl

prefLabel

Application of EGFR inhibitor ...... atheter arterial embolization.

@en

Application of EGFR inhibitor ...... atheter arterial embolization.

@nl

P1476

Application of EGFR inhibitor ...... catheter arterial embolization

@en

P2093

J Wang

http://www.w3.org/2001/XMLSchema#string

L Zhu

http://www.w3.org/2001/XMLSchema#string

S Qian

http://www.w3.org/2001/XMLSchema#string

W Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

CXCR4 over-expression and survival in cancer: a system review and meta-analysis

Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma

Macrophage plasticity and polarization: in vivo veritas

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenib.

EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation.

Novel advancements in the management of hepatocellular carcinoma in 2008.

Wound healing and its impairment in the diabetic foot.

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma.

P2888

s12094-017-1761-8

P304

639-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-017-1761-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

R Liu

P577

2017-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29022239

http://www.w3.org/2001/XMLSchema#string